The Protein Kinase A Pathway Inhibits c-jun and c-fos Protooncogene Expression Induced by the Protein Kinase C and Tyrosine Kinase Pathways in Cultured Human Thyroid Follicles1
R. Heinrich and
Z. Kraiem
Endocrine Research Unit, Carmel Medical Center and the Rappaport
Faculty of Medicine, Technion-Israel Institute of Technology, Haifa,
Israel
Address all correspondence and requests for reprints to: Z. Kraiem, Ph.D., Endocrine Research Unit, Carmel Medical Center, 7 Michal Street, Haifa 34362, Israel.
We have previously demonstrated antagonistic interactions betweenthe
major signal transduction pathways in human thyroid follicles:TSH
acting via protein kinase A (PKA) attenuated phorbol ester[acting via
protein kinase C (PKC)] as well as epidermal growthfactor
(EGF)-protein tyrosine kinase (PTK)-mediated cell proliferation,
whereasthe PKC and PTK pathways inhibited PKA-mediated cell
differentiation.In view of the key role played by the protooncogenes
c-jun andc-fos in the cascade of events leading
to cell proliferationand differentiation, we examined whether the
antagonism we observedbetween the pathways could be related to changes
in the expressionof these genes. The experimental model used was the
same invitro system as that used in the above study on
cell growthand differentiation: thyroid follicles of human origin
culturedin suspension under serum-free conditions. Both EGF (150
ng/mL)and the phorbol ester 12-O-tetradecanoylphorbol
13-acetate (TPA;10-11-10-7 mol/L) dose and
time dependently stimulated c-junand c-fos
messenger ribonucleic acid (mRNA) expression. Thec-jun and
c-fos mRNA stimulation elicited by TPA was reducedby the
PKC inhibitors, chelerythrine and staurosporine, andcould not be
mimicked by 4-phorbol 12,13-didecanoate (a phorbolester that fails
to activate PKC), whereas the stimulation inducedby EGF was diminished
by the PTK inhibitor, genistein. Thisindicates a PKC- and PTK-mediated
pathway triggered by TPA andEGF, respectively. TSH induced an increase
in c-jun and c-fosmRNA, which, though
significant, was small compared to thatelicited by TPA or EGF.
Addition of TSH (0.10.5 mU/mL),however, to either TPA or EGF dose
dependently inhibited thec-jun and c-fos mRNA
elicited by these agents. The repressiveaction of TSH on the effects
of TPA and EGF mRNA were mimickedby forskolin and 8-bromo-cAMP,
suggesting that the TSH inhibitoryaction is PKA mediated. The TSH
inhibitory action seems to requirede novo protein
synthesis, as it was abrogated in the presenceof cycloheximide.
In conclusion, the present study provides novel data on
c-junand c-fos gene expression and their
modulation by the majorsignal transduction pathways operating in human
thyrocytes.Moreover, using the same serum-free system of human thyroid
folliclescultured with the same agents and at the same doses as in our
previousstudy on cell growth and differentiation, we found the TSH/PKA
pathwayto inhibit PKC- and EGF/tyrosine kinase-induced
c-jun and c-fosmRNA, i.e.
antagonistic effects parallel to those previouslyobserved measuring
cell proliferation. The findings suggestan association between human
thyroid cell proliferation andc-jun and c-fos
gene expression.
This article has been cited by other articles:
S. Romano, A. Muscella, C. Storelli, and S. Marsigliante Angiotensin II does not stimulate proliferation of rat thyroid PC Cl3 cell line
J. Endocrinol.,
December 1, 2006;
191(3):
727 - 735.
[Abstract][Full Text][PDF]
S. Paternot, J. E. Dumont, and P. P. Roger Differential Utilization of Cyclin D1 and Cyclin D3 in the Distinct Mitogenic Stimulations by Growth Factors and TSH of Human Thyrocytes in Primary Culture
Mol. Endocrinol.,
December 1, 2006;
20(12):
3279 - 3292.
[Abstract][Full Text][PDF]
A. Shih, S. Zhang, H. J. Cao, H.-Y. Tang, F. B. Davis, P. J. Davis, and H.-Y. Lin Disparate Effects of Thyroid Hormone on Actions of Epidermal Growth Factor and Transforming Growth Factor-{alpha} Are Mediated by 3',5'-Cyclic Adenosine 5'-Monophosphate-Dependent Protein Kinase II
Endocrinology,
April 1, 2004;
145(4):
1708 - 1717.
[Abstract][Full Text][PDF]
T. C. Peterson, M. R. Peterson, H. A. Robertson, M. During, and M. Dragunow Selective Down-Regulation of c-jun Gene Expression by Pentoxifylline and c-jun Antisense Interrupts Platelet-Derived Growth Factor Signaling: Pentoxifylline Inhibits Phosphorylation of c-Jun on Serine 73
Mol. Pharmacol.,
June 1, 2002;
61(6):
1476 - 1488.
[Abstract][Full Text][PDF]
T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models
Endocr. Rev.,
October 1, 2001;
22(5):
631 - 656.
[Abstract][Full Text][PDF]
N. Fernandez, M. J. Caloca, G. V. Prendergast, J. L. Meinkoth, and M. G. Kazanietz Atypical Protein Kinase C-{zeta} Stimulates Thyrotropin-Independent Proliferation in Rat Thyroid Cells
Endocrinology,
January 1, 2000;
141(1):
146 - 152.
[Abstract][Full Text][PDF]
S. Korem, M. B. Resnick, and Z. Kraiem Similar and Divergent Patterns in the Regulation of Matrix Metalloproteinase-1 (MMP-1) and Tissue Inhibitor of MMP-1 Gene Expression in Benign and Malignant Human Thyroid Cells
J. Clin. Endocrinol. Metab.,
September 1, 1999;
84(9):
3322 - 3327.
[Abstract][Full Text]
T. Hara, H. Namba, N. Takamura, T.-T. Yang, Y. Nagayama, S. Fukata, K. Kuma, N. Ishikawa, K. Ito, and S. Yamashita Thyrotropin Regulates c-Jun N-Terminal Kinase (JNK) Activity through Two Distinct Signal Pathways in Human Thyroid Cells
Endocrinology,
April 1, 1999;
140(4):
1724 - 1730.
[Abstract][Full Text]
M. Derwahl, M. Broecker, and Z. Kraiem Thyrotropin May Not Be the Dominant Growth Factor in Benign and Malignant Thyroid Tumors
J. Clin. Endocrinol. Metab.,
March 1, 1999;
84(3):
829 - 834.
[Full Text]